Akoya Biosciences Inc. (AKYA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.78M 83.13M 74.23M 113.08M
Short-Term Investments
23.26M n/a 6.99M n/a
Long-Term Investments
n/a 699K 303K 302K
Other Long-Term Assets
2.47M 1.55M 3.08M 3.19M
Receivables
13.78M 16.99M 9.73M 9.44M
Inventory
24.32M 17.88M 14.49M 9.01M
Other Current Assets
3.59M 3.79M 6.76M n/a
Total Current Assets
76.73M 121.79M 112.2M 140.81M
Property-Plant & Equipment
12.98M 20.66M 22.45M 7.49M
Goodwill & Intangibles
32.82M 35.67M 38.31M 39.41M
Total Long-Term Assets
48.27M 58.58M 63.83M 50.09M
Total Assets
125M 180.37M 176.03M 190.91M
Account Payables
8.76M 11.78M 10.63M 9.44M
Deferred Revenue
6.55M 6.69M 6.28M 4.48M
Short-Term Debt
3.28M n/a n/a 272K
Other Current Liabilities
3.15M 6.36M 8.23M 6.72M
Total Current Liabilities
29.44M 35.34M 37.05M 27.68M
Long-Term Debt
76.18M 75.25M 63.28M 32.47M
Other Long-Term Liabilities
3.91M 5.76M 6.04M 7.85M
Total Long-Term Liabilities
87.97M 91.25M 80.39M 41.87M
Total Liabilities
117.41M 126.6M 117.45M 69.56M
Total Debt
84.15M 85.71M 75.78M 32.94M
Common Stock
2K 2K 2K 2K
Retained Earnings
-285.44M -230.07M -166.75M -96.11M
Comprehensive Income
7K n/a -6K n/a
Shareholders Equity
7.59M 53.77M 58.58M 121.35M
Total Investments
23.26M 699K 6.99M 302K